After 48 h, the cells were washed with PBS (Gibco) and incubated in the assay buffer (HBSS supplemented with Ca 2+ and Mg 2+ (Gibco), 10 mM HEPES (Gibco), 0.1% Pluronic F-68 (Gibco) and 500 M IBMX (Sigma), pH 7.4) with different concentrations of GLP-1 (0 M to 1 M) in the presence (100 nM and 1000 nM) or absence of Fab7F38 at 37 C for 30 min
Future research should aim to clarify the GLP-1RA-specific benefits and mechanisms in HFpEF, which would help to integrate them more effectively into therapeutic regimens.
Current Availability and Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA as of 2025 and cannot be legally prescribed in the UK
Developed with input from GLP-1 clinicians and obesity-specialist dietitians, the app brings key health data into one place so users can spot patterns, build consistent routines and feel more confident managing their treatment, putting practical support inside their pocket
[5] [2] Common examples available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
